Terbinafine Hydrochloride Tablet
Product Images NDC 51991-526

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Terbinafine Hydrochloride (NDC 51991-526). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Breckenridge Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Terbinafine 01)

FDA Label Image

Principal Display Panel (250 mg Tablet Bottle Label)

Principal Display Panel (250 mg Tablet Bottle Label)
Each tablet contains terbinafine hydrochloride 250 mg. The usual adult dosage information can be found in the package insert. The pharmacist is required to distribute the medication guide separately to each patient. The tablets should be stored at a controlled room temperature and protected from light. The product is distributed by Breckenridge Pharmaceuticals and manufactured by Iconsa in Guadalojora, Spain. The batch number is 4794601 and the expiration date is April 2020.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.